Bölge seçiniz

Haber akışımıza abone olun

Abone ol

Bir soru?

Bize Ulaşın

21.10.2025

Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds

“We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech company’s net sales increased organically by 9,5% while order intake rose by 4,7% organically.

Düzenleyici

21.10.2025
Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds

“We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech company’s net sales increased organically by 9,5% while order intake rose by 4,7% organically.
13.10.2025

Getinge’s Advanta V12 receives CE Mark for major bridging indications

Getinge’s Advanta™ V12 is now approved for major bridging indications, marking a milestone in complex aortic aneurysm treatment.

Basın bülteni

13.10.2025
Getinge’s Advanta V12 receives CE Mark for major bridging indications

Getinge’s Advanta™ V12 is now approved for major bridging indications, marking a milestone in complex aortic aneurysm treatment.
7.10.2025

Getinge invites fund managers, analysts, and media to Q3 Report 2025 conference call

Getinge will issue its Q3 Report 2025 on October 21, 2025, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

Basın bülteni

7.10.2025
Getinge invites fund managers, analysts, and media to Q3 Report 2025 conference call

Getinge will issue its Q3 Report 2025 on October 21, 2025, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.
2.10.2025

Getinge and Philips introduce integrated anesthesia workstation

Getinge and Philips have joined forces to offer hospitals an integrated anesthesia workstation for the operating room (OR). The new solution unites precise anesthesia delivery and state-of-the-art patient monitoring.

Basın bülteni

2.10.2025
Getinge and Philips introduce integrated anesthesia workstation

Getinge and Philips have joined forces to offer hospitals an integrated anesthesia workstation for the operating room (OR). The new solution unites precise anesthesia delivery and state-of-the-art patient monitoring.
4.08.2025

EU CE-Mark Reinstated for Cardiosave Intra-Aortic Balloon Pump

Today, Getinge announces that the EU Notified Body TÜV SÜD has reinstated the EU CE Mark for Getinge’s Cardiosave Intra-Aortic Balloon Pump (through the issuance of an updated EU Medical Device Directive (MDD) Confirmation Letter).

Basın bülteni

4.08.2025
EU CE-Mark Reinstated for Cardiosave Intra-Aortic Balloon Pump

Today, Getinge announces that the EU Notified Body TÜV SÜD has reinstated the EU CE Mark for Getinge’s Cardiosave Intra-Aortic Balloon Pump (through the issuance of an updated EU Medical Device Directive (MDD) Confirmation Letter).
18.07.2025

Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions

“The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and sales, and our margins strengthened despite strong headwinds from tariffs and negative currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 4.1% while order intake rose by 4.4% organically.

Düzenleyici

18.07.2025
Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions

“The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and sales, and our margins strengthened despite strong headwinds from tariffs and negative currency effects,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 4.1% while order intake rose by 4.4% organically.

Basın iletişim

Alexandra Holland

Alexandra Holland

EVP Brand & Communication
Phone: +1 908 930 8661

Email
Caroline Örmgård, Getinge Head of Public & Media Relations

Caroline Örmgård

Head of Public & Media Relations
Phone: +46 10 335 0041

Email
Katarzyna Sypula,Senior CX Campaigns & Events Manager, Getinge

Katarzyna Sypuła

Senior Customer Experience Campaigns & Events Manager 
CEE/ South Europe / SAPAC
Tel: +48 661 705 706

Email
Newsroom2

Bizimle çevrimiçi iletişime geçmeyi mi tercih ediyorsunuz?

Uygun formu doldurmak için aşağıya tıklayın. Yakında sizinle iletişime geçeceğiz!

Formu doldurun

Mı arıyorsun

Getinge Hybrid OR

Resim Galerisi

Basın makalesi amacıyla kullanıma sunulan çeşitli resim formatı

Galeriye git
Man and woman looking a something together

Hakkımızda

Bir bakışta Getinge hakkında bilmeniz gereken her şey

Getinge hakkında daha fazla bilgi edinin
Cardiosave

Acil Tıbbi Cihaz Düzeltmesi

CARDIOSAVE intra-aortik balon pompası (IABP) için Gönüllü Acil Tıbbi Cihaz Saha Düzeltmesi

Bildirimi okuyun
Newsroom

Hiçbir şeyi kaçırma

Simgelere tıklayın ve bizi takip edin!

 

     

Şu anda Getinge.com'dan ayrılıyorsunuz. Getinge ekibi tarafından yönetilmeyen içeriğe erişebilirsiniz, bu durumda Getinge içerikten sorumlu tutulamaz. 

Anlıyorum!